Qube Research & Technologies (QRT)
SURF

Qube Research & Technologies (QRT)’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-30,311
Closed -$32K – 3150
2022
Q3 		$32K Sell
30,311
-2,832
-9% -$4.53K ﹤0.01% 2226
2022
Q2 		$54K Buy
+33,143
New +$68.8K ﹤0.01% 2107
2022
Q1 		– Sell
-25,371
Closed -$121K – 3182
2021
Q4 		$121K Buy
+25,371
New +$164K ﹤0.01% 2098
2021
Q3 		– Sell
-10,864
Closed -$81K – 2941
2021
Q2 		$81K Sell
10,864
-35,751
-77% -$276K ﹤0.01% 1975
2021
Q1 		$364K Sell
46,615
-74,529
-62% -$745K 0.01% 1356
2020
Q4 		$1.12M Buy
121,144
+28,812
+31% +$250K 0.02% 837
2020
Q3 		$637K Buy
92,332
+77,110
+507% +$468K 0.01% 954
2020
Q2 		$100K Buy
+15,222
New +$54.9K ﹤0.01% 1516

Other funds holding SURF

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SURF Position: Q4 2022 in Review

Qube Research & Technologies (QRT) sold out of Surface Oncology, Inc. Common Stock (SURF) in Q4 2022, closing a stake of 30,311 shares — an estimated $32K sold.

Qube Research & Technologies (QRT) first reported a position in SURF in Q2 2020 and held it in 8 quarters. The position peaked at $1.12M in Q4 2020. 79 funds tracked by Wall St. Rank hold SURF as of Q4 2022.

  • Qube Research & Technologies (QRT) reported no remaining Surface Oncology, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 30,311 Surface Oncology, Inc. Common Stock shares in Q4 2022, an estimated $32K.
  • Qube Research & Technologies (QRT) first reported a position in Surface Oncology, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
  • Qube Research & Technologies (QRT)'s Surface Oncology, Inc. Common Stock position peaked at $1.12M in Q4 2020.
  • 79 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q4 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.